HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Cullinane, C. A. Articles by Grannis, F. W. Search for Related Content PubMed PubMed Citation Articles by Cullinane, C. A. Articles by Grannis, F. W., Jr

Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient With Concurrent Malignancy^*

^* From the Section of Thoracic and Vascular Surgery (Dr. Grannis), Division of General Oncologic Surgery (Drs. Cullinane and Paz), and Department of Biostatistics (Dr. Smith and Ms. Carter), City of Hope National Medical Center, Los Angeles, CA.

Correspondence to: Frederic W. Grannis, Jr., MD, FCCP, Department of Surgery, 1500 East Duarte Road, Duarte, CA 91010; e-mail: fgrannis{at}coh.org

Background: Pericardial effusion in the patient with cancer presents a unique management problem. Although multiple methods of operative and nonoperative drainage of pericardial effusions have been described, surgical pericardial window remains the standard approach to long-term drainage. Selecting the patient who may benefit from an operative approach presents a difficult challenge. In the present study, we retrospectively analyzed the clinical outcome of 63 consecutive patients with malignancy who underwent surgical pericardial window for symptomatic pericardial effusion between January 1, 1990, and July 1, 2001, at City of Hope National Medical Center in order to try to determine whether the type of cancer, the presence of malignant cells in pericardial fluid, or tissue specimens or the method of surgery influenced the incidence of recurrent pericardial effusion or duration of survival.

Methods: The cohort was comprised of 15 patients with non-small cell lung cancer (NSCLC), 22 patients with breast cancer, 17 patients with hematologic malignancy, and 9 patients with other solid tumors. Pertinent clinical, laboratory, hospital stay, and outcome data including long-term follow-up were recorded. Patients were followed up until the time of last clinical follow-up or death. Univariate survival analyses were performed to determine significant clinical factors contributing to outcome.

Results: Median follow-up was 6.6 months for the group and 8.3 months for those alive at last follow-up. Median survival rates for patients with lung, breast, hematologic, and other solid-tumor malignancies were 3.2 months, 8.8 months, 17 months, and 16.4 months, respectively. Preoperative factors that negatively correlated with survival included a diagnosis of NSCLC (p = 0.0014), the presence of a pleural effusion (p = 0.003), or positive pathologic (p = 0.02) or cytologic findings (p = 0.02).

Conclusions: A surgical approach to pericardial drainage is effective (< 5% failure rate) and provides an opportunity for continued therapy with the potential for relief of dyspnea and improvement in quality of life and survival in selected patients.

Key Words: cardiac tamponade • malignancy • palliative surgery • pericardial effusion • pericardial window

This article has been cited by other articles:

				J. L. Gross, R. N. Younes, D. Deheinzelin, A. L. Diniz, R. A. da Silva, and F. J. Haddad Surgical Management of Symptomatic Pericardial Effusion in Patients with Solid Malignancies Ann. Surg. Oncol., December 1, 2006; 13(12): 1732 - 1738. [Abstract] [Full Text] [PDF]

				P. K.H. O'Brien, J. C. Kucharczuk, M. B. Marshall, J. S. Friedberg, Z. Chen, L. R. Kaiser, and J. B. Shrager Comparative Study of Subxiphoid Versus Video-Thoracoscopic Pericardial "Window" Ann. Thorac. Surg., December 1, 2005; 80(6): 2013 - 2019. [Abstract] [Full Text] [PDF]

				H. L. Gornik, M. Gerhard-Herman, and J. A. Beckman Abnormal Cytology Predicts Poor Prognosis in Cancer Patients With Pericardial Effusion J. Clin. Oncol., August 1, 2005; 23(22): 5211 - 5216. [Abstract] [Full Text] [PDF]

				N. Uribe-Etxebarria, R. Voces, M. A. Rodriguez, A. Llorente, P. Perez, and J. I. Aramendi Reversible Tricuspid Valve Stenosis Due to a Metastatic Dissemination of a Noncardiac Sarcoma Ann. Thorac. Surg., July 1, 2005; 80(1): e1 - e2. [Abstract] [Full Text] [PDF]

				K. M. Frankel, F. W. Grannis Jr, C. A. Cullinane, and I. B. Paz Malignant Pericardial Effusions Chest, November 1, 2004; 126(5): 1713 - 1713. [Full Text] [PDF]